'Normal' B12 Isn't Enough: UCSF Rewrites the Cognitive Threshold
SCIENCE

'Normal' B12 Isn't Enough: UCSF Rewrites the Cognitive Threshold

By Jin · · UCSF / Pharmacy Times
KO | EN

A 2025 UCSF study concluded that the vitamin B12 reference standard itself needs revisiting. Healthy older volunteers with B12 levels at the low end of the normal range showed neurological and cognitive deficits including brain white-matter damage and slower cognitive and visual processing speeds.

What “Normal” Means Is Shifting

Clinical labs currently use a B12 “normal” range of 200-900 pg/mL. Inside this range, patients are generally labeled “not deficient.” The UCSF study showed that older adults at the low end (200-300 pg/mL) experienced significant increases in white-matter hyperintensities (WMH) and declines in cognitive and visual processing speed.

WMH is an MRI marker of brain injury and a predictor of vascular dementia and cognitive decline. Having a “normal” label does not guarantee functional brain health.

Neurological Symptoms Come Before Anemia

The most familiar B12 deficiency symptom is megaloblastic anemia. In clinical practice, however, neurological symptoms often appear first: numbness in hands and feet, balance problems, memory and focus declines, fatigue, depression, oral pain, and tongue changes.

The UCSF study is important because it demonstrates that subtle cognitive decline can progress even when anemia is absent and B12 is labeled “normal.”

Who Needs Supplementation

The at-risk groups are well defined:

  • Age 60+: reduced stomach acid lowers dietary B12 absorption
  • Strict vegan diets: B12 comes exclusively from animal foods
  • GLP-1 drug users: acid reduction impairs absorption
  • Long-term metformin users: diabetic medication interferes with B12
  • Gastric surgery or Crohn’s patients: absorption pathways are limited

For these groups, supplementation is reasonable even at low-normal B12 levels. Homocysteine and methylmalonic acid (MMA) serve as more sensitive markers of functional B12 status.

Dosing and Forms

Adult RDA: 2.4 μg/day Clinical dosing: 500-1,000 μg (with neurological symptoms) Oral vs. injection: meta-analyses show high-dose oral (1,000 μg) matches injection efficacy. Injections are reserved for severe absorption problems.

Form comparison:

  • Cyanocobalamin: cheapest and most stable
  • Methylcobalamin: claimed to have higher bioavailability in nervous tissue. More expensive
  • Hydroxocobalamin: primarily used in injections

Dietary B12 Sources

B12-rich foods: clams (84 μg per 100 g), liver (beef liver 70 μg per 100 g), sardines (9 μg per 100 g), beef (6 μg per 100 g), eggs (0.6 μg per egg), milk (1.2 μg per cup).

On a vegan diet, fortified foods (B12-fortified plant milks, nutritional yeast) and supplementation are essential. Strict vegan intake beyond one year typically drops B12 below low-normal without supplementation.

From a Cognitive Decline Prevention Lens

B12 is one of the clearest preventable cognitive decline factors. Neurological damage is hard to reverse, but nutrients that can stop or slow progression are rare. Checking B12, homocysteine, and MMA periodically from the mid-40s onward is one of the cheapest investments in brain health 10-20 years out.

“Normal” may not mean “sufficient.” That is the UCSF study’s central message.